About the Authors
- Marc Liesa
-
Affiliations Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain, Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain, CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain
- Bárbara Borda-d'Água
-
Affiliations Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain, Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain
- Gema Medina-Gómez
-
Affiliation Institute of Metabolic Science, Metabolic Research Laboratories, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom
- Christopher J. Lelliott
-
Affiliation Department of Biosciences, AstraZeneca R&D, Mölndal, Sweden
- José Carlos Paz
-
Affiliations Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain, Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain, CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain
- Manuel Rojo
-
Affiliation Institut de Biochimie et Génétique Cellulaires (IBGC) CNRS UMR5095, Université Victor Segalen, Bordeaux, France
- Manuel Palacín
-
Affiliations Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain, Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain
- Antonio Vidal-Puig
-
Affiliation Institute of Metabolic Science, Metabolic Research Laboratories, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom
- Antonio Zorzano
-
* E-mail: antonio.zorzano@irbbarcelona.org
Affiliations Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain, Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain, CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain
Competing Interests
Christopher J. Lelliott is an employee and stock-holder of Astra Zeneca R&D.
Author Contributions
Conceived and designed the experiments: ML AZ. Performed the experiments: ML BBd GMG CJL JCP. Analyzed the data: ML MP AJVP AZ. Contributed reagents/materials/analysis tools: ML GMG CJL MR MP AJVP. Wrote the paper: ML AZ.